Barbara Weber
2021
In 2021, Barbara Weber earned a total compensation of $11.5M as President, Chief Executive Officer and Director at Tango Therapeutics, a 1,102% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $277,910 |
|---|---|
| Option Awards | $10,719,769 |
| Salary | $513,685 |
| Other | $4,609 |
| Total | $11,515,974 |
Weber received $10.7M in option awards, accounting for 93% of the total pay in 2021.
Weber also received $277.9K in non-equity incentive plan, $513.7K in salary and $4.6K in other compensation.
Rankings
In 2021, Barbara Weber's compensation ranked 838th out of 12,406 executives tracked by ExecPay. In other words, Weber earned more than 93.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 838 out of 12,406 | 93rd |
Division Manufacturing | 274 out of 5,492 | 95th |
Major group Chemicals And Allied Products | 91 out of 2,368 | 96th |
Industry group Drugs | 76 out of 2,089 | 96th |
Industry Pharmaceutical Preparations | 48 out of 1,536 | 97th |
Source: SEC filing on April 26, 2022.
Weber's colleagues
We found two more compensation records of executives who worked with Barbara Weber at Tango Therapeutics in 2021.